Search
Nolasiban
go.drugbank.com/drugs/DB16259InvestigationalNolasiban is under investigation in clinical trial NCT03081208 (Phase 3 Placebo Controlled Study of Nolasiban to Improve Pregnancy Rates in Women Undergoing IVF/ICSI).
Povorcitinib
go.drugbank.com/drugs/DB18855InvestigationalPovorcitinib is under investigation in clinical trial NCT06113445 (A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)).
3-Fluoro-L-tyrosine
go.drugbank.com/drugs/DB04436Experimental3-Fluoro-L-tyrosine is a solid. This compound belongs to the phenylpropanoic acids. … These are compounds whose structure contain a benzene ring conjugated to a propanoic acid. 3-Fluoro-L-tyrosine targets the protein superoxide dismutase [mn], mitochondrial.
Clorobiocin
go.drugbank.com/drugs/DB03966ExperimentalClorobiocin is an aminocoumarin antibiotic, similar to [novobiocin] and coumermycin A1.
Pradigastat
go.drugbank.com/drugs/DB12866InvestigationalPradigastat has been used in trials studying the treatment of Non-alcoholic Fatty Liver Disease (NAFLD).
DYN-101
go.drugbank.com/drugs/DB17921InvestigationalDYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein.
Sirpiglenastat
go.drugbank.com/drugs/DB17536InvestigationalIt is under investigation in clinical trial NCT04471415 (Study to Investigate DRP-104 in Adults With Advanced Solid Tumors). … Sirpiglenastat, also known as DRP-104, is a prodrug of [6-diazo-5-oxo-L-norleucine] (DON), which is a broad-acting glutamine antagonist.
Synonyms: L-norleucine, n-acetyl-l-tryptophyl-6-diazo-5-oxo-, 1-methylethyl ester, Propan-2-yl (2s)-2-((n-acetyl-l-tryptophyl)amino)-6-diazo-5-oxohexanoateL-lysyl-l-arginine
go.drugbank.com/drugs/DB19436InvestigationalL-lysyl-l-arginine is under investigation in clinical trial NCT03972488 (Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET).
S-777469
go.drugbank.com/drugs/DB16321InvestigationalS-777469 is under investigation in clinical trial NCT00703573 (A Randomized, Double-blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis).
Tiragolumab
go.drugbank.com/drugs/DB16409InvestigationalTiragolumab is under investigation in clinical trial NCT04513925 (A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-small